Procyrion, Inc. To Present Aortix™ Abstract At American Society for Artificial Internal Organs 60th Annual Conference


HOUSTON, TX (May 12, 2014) - Following blind peer review, Procyrion Inc.’s abstract, “Aortix™ Percutaneous Circulatory Assist Device Decreases Afterload, Improves Renal Function in Chronic HF,” has been selected for oral presentation at the American Society for Artificial Internal Organs (ASAIO) 60th annual conference scheduled for June 18 – 21 in Washington D.C.  Procyrion’s abstract was among 281 submitted for consideration.

“Oral presentation slots are limited and oversubscribed at high-profile conferences like ASAIO.  This is a great opportunity for us to showcase our first-in-class technology and latest data to a wider audience of industry experts,” says Procyrion’s chief operating officer Jace Heuring, Ph.D., who will present the technology at the conference.

Conceived by Dr. Reynolds M. Delgado III, medical director of Mechanical Support at the Texas Heart Institute, Aortix is a percutaneous intra-aortic continuous flow pump delivered by a catheter inserted through the femoral artery and held in place using novel self-expanding anchors.  The small size and unique design of the device enable a minimally invasive outpatient procedure that takes about ten minutes to complete.ASAIO’s mission is to provide a forum that globally and collaboratively promotes the development of innovative medical device technology at the crossroads of science, engineering, and medicine.  Dedicated sessions are devoted to pediatric and adult mechanical circulatory support, respiratory assist, and VAD coordinator training.

Houston-based medical device firm Procyrion, Inc. is developing the first catheter-deployed, intra-aortic pump for ambulatory use. The device is designed to rest and heal the heart by reducing afterload while simultaneously improving blood flow to vital organs. This groundbreaking cardiology tool, conceived by cardiologist Dr. Reynolds M. Delgado, III, medical director of Mechanical Support Devices in Heart Failure at the Texas Heart Institute, is expected to provide a minimally invasive treatment option for millions of chronic heart failure patients.  For more information, visit or call 713.579.9227.

Read More